Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Immunology
Assuntos:	multiple sclerosis cladribine biomarkers omics bioinformatics
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!